Lung Cancers Active Not Recruiting Phase 2 Trials for Nivolumab (DB09035)

Also known as: LUng Cancer / Cancer, Lung / Lung neoplasm malignant / Lung cancer NOS / Cancer of lung / Ca lung

IndicationStatusPhase
DBCOND0072929 (Lung Cancers)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02664181Rational EpigenetiC Immunotherapy for SEcond Line Therapy in Patients With NSCLC: PRECISE TrialTreatment